European researchers report that the beta-blocker Coreg may be more effective in preventing heart failure than metroprolol. The study, funded by Coreg maker GlaxoSmithKline, cautioned the results may not be entirely accurate given the type of metroprolol used in the study.
Tamoxifen is the top choice of doctors for breast cancer survivors and high risk women, although the side effects can be life-threatening. A small group of scientists, however, is going to try and change all that by simply lowering the dose; proving its effectiveness may be difficult.
Using genetic analysis, researchers have concluded that women who have endometriosis, which causes painful menstruation, often have defective genes that prevent embryos from attaching to the uterus, preventing pregnancy.
USDA Secretary Ann Veneman told attendees of an international biotechnology conference that genetically modified foods are key to reduce global hunger. But demonstrators say biotechnology isn't the answer to global food problems, criticizing the conference as a U.S. way to lower trade barriers. Click here to read the USDA release.